These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 22331103)
1. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation. Joshi SK; Lang GA; Devera TS; Johnson AM; Kovats S; Lang ML J Leukoc Biol; 2012 May; 91(5):783-90. PubMed ID: 22331103 [TBL] [Abstract][Full Text] [Related]
2. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity. Li Y; Zhao C; Liu J; Lu Z; Lu M; Gu J; Liu R Oncol Rep; 2019 May; 41(5):2679-2688. PubMed ID: 30864713 [TBL] [Abstract][Full Text] [Related]
3. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Lang GA; Exley MA; Lang ML Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697 [TBL] [Abstract][Full Text] [Related]
4. In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances. Ishii R; Shimizu M; Nakagawa Y; Shimizu K; Tanaka S; Takahashi H Cancer Immunol Immunother; 2004 May; 53(5):383-90. PubMed ID: 14624311 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Moll M; Andersson SK; Smed-Sörensen A; Sandberg JK Blood; 2010 Sep; 116(11):1876-84. PubMed ID: 20530791 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses. Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323 [TBL] [Abstract][Full Text] [Related]
7. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory. Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691 [TBL] [Abstract][Full Text] [Related]
8. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers. Singh AK; Rhost S; Löfbom L; Cardell SL Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185 [TBL] [Abstract][Full Text] [Related]
9. Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis. Rzemieniak SE; Hirschfeld AF; Victor RE; Chilvers MA; Zheng D; van den Elzen P; Turvey SE Immunology; 2010 Jun; 130(2):288-95. PubMed ID: 20102408 [TBL] [Abstract][Full Text] [Related]
10. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739 [TBL] [Abstract][Full Text] [Related]
11. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo. Stober D; Jomantaite I; Schirmbeck R; Reimann J J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280 [TBL] [Abstract][Full Text] [Related]
12. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice. Wang HX; Li WJ; Hou CL; Lai S; Zhang YL; Tian C; Yang H; Du J; Li HH Cardiovasc Res; 2019 Jan; 115(1):83-93. PubMed ID: 29939225 [TBL] [Abstract][Full Text] [Related]
13. B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells. Brandl C; Ortler S; Herrmann T; Cardell S; Lutz MB; Wiendl H PLoS One; 2010 May; 5(5):e10800. PubMed ID: 20520738 [TBL] [Abstract][Full Text] [Related]
14. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells. Gerth E; Mattner J Front Immunol; 2019; 10():1449. PubMed ID: 31293596 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells. Webb TJ; Bieler JG; Schneck JP; Oelke M J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558 [TBL] [Abstract][Full Text] [Related]
16. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells. Webb TJ; Giuntoli RL; Rogers O; Schneck J; Oelke M Clin Cancer Res; 2008 Dec; 14(23):7652-8. PubMed ID: 19047090 [TBL] [Abstract][Full Text] [Related]
17. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens. Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925 [TBL] [Abstract][Full Text] [Related]
18. CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs. Wang C; Liu X; Li Z; Chai Y; Jiang Y; Wang Q; Ji Y; Zhu Z; Wan Y; Yuan Z; Chang Z; Zhang M Sci Rep; 2015 Sep; 5():14124. PubMed ID: 26369936 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646 [TBL] [Abstract][Full Text] [Related]
20. NKT-cell help to B lymphocytes can occur independently of cognate interaction. Tonti E; Galli G; Malzone C; Abrignani S; Casorati G; Dellabona P Blood; 2009 Jan; 113(2):370-6. PubMed ID: 18832653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]